MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
Hospital Ramón y Cajal
Madrid, EspañaHospital Ramón y Cajal -ko ikertzaileekin lankidetzan egindako argitalpenak (19)
2022
-
Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study
Medicine (United States), Vol. 101, Núm. 42, pp. E31175
2021
-
Follow-up care over 12months of patients with prostate cancer in Spain A multicenter prospective cohort study
Medicine (United States), Vol. 100, Núm. 47
-
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study
BMC Infectious Diseases, Vol. 21, Núm. 1
2020
-
Factors associated with the number of drugs in darunavir/cobicistat regimens
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214
-
Fried-Food Consumption Does Not Increase the Risk of Stroke in the Spanish Cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC) Study
The Journal of nutrition, Vol. 150, Núm. 12, pp. 3241-3248
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2017
-
Clinical interval and diagnostic characteristics in a cohort of bladder cancer patients in Spain: a multicenter observational study
BMC research notes, Vol. 10, Núm. 1, pp. 708
-
Costs associated with influenza-related hospitalization in the elderly
Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416
-
Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain
PLoS ONE, Vol. 12, Núm. 2
2015
-
Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: A multicentre observational study
BMC Urology, Vol. 15, Núm. 1
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2014
-
Add-On Treatment with Pregabalin for Patients with Uncontrolled Neuropathic Pain Who Have Been Referred to Pain Clinics
Clinical Drug Investigation, Vol. 34, Núm. 12, pp. 833-844
-
Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation
Health and Quality of Life Outcomes, Vol. 12, Núm. 1
-
Clinical characteristics, patient-reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinics
Pain Research and Treatment, Vol. 2014
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
-
Lung cancer in women: An overview with special focus on Spanish women
Clinical and Translational Oncology, Vol. 16, Núm. 6, pp. 517-528
2013
-
Casos autodeclarados de síndrome gripal en trabajadores sanitarios españoles durante la pandemia de gripe A (H1N1) 2009
Gaceta Sanitaria, Vol. 27, Núm. 2, pp. 167-170
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849